StockData
Savara Inc logo

Savara Inc (SVRA) stock

SVRANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 4/30
$4.48+0.02 (+0.34%)

Close on Nov 17, 2026Market cap $920.46MP/E –Yield –

Savara enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Savara's enterprise value was $882.02M on Nov 11, 2026, against $1.26B a year earlier. Over the last 5 years it ranged from -$5.23M to $1.26B, with a median of $379.09M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$882.02M-27.0%
2025Dec 31, 2025$1.21B+264.5%
2024Dec 31, 2024$331.60M-32.9%
2023Dec 29, 2023$494.13M+619.3%
2022Dec 30, 2022$68.70M–
2021Dec 31, 2021-$4.09M–
2020Dec 31, 2020-$32.07M-140.9%
2019Dec 31, 2019$78.33M-49.1%
2018Dec 31, 2018$153.81M-50.2%
2017Dec 29, 2017$308.65M–
2016Dec 30, 2016-$6.79M–

More Savara figures

See a number that looks wrong?